Andrew D. Ashe, See Remarks at Verve Therapeutics, Inc. (VERV), bought 76,000 shares at $6.26 ($476K) on 2024-05-14, disclosed to the SEC on 2024-05-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| DYAX | SELL | 2015-08-05 | $1.5M | — | Filing → |
| DYAX | SELL | 2015-03-06 | $37K | — | Filing → |
| DYAX | SELL | 2015-02-26 | $23K | — | Filing → |